FDA Drug Approval Guidance: What You Need to Know
By Dan McKay · December 10, 2024, 6:43 PM EST
Federal regulators may set clinical trial enrollment targets and impose other conditions on certain studies that pharmaceutical companies must carry out under an accelerated drug-approval program, according to new draft guidance...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login